Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2011

01.06.2011

Towards a personalised approach to aftercare: a review of cancer follow-up in the UK

verfasst von: Nicola J. Davies, Lynn Batehup

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Due to growth in cancer survivorship and subsequent resource limitations, the current UK position of follow-up services is unsustainable. With people living longer after a cancer diagnosis, supported self-management for ongoing treatment-related chronic conditions is a fundamental component of aftercare services. Alternative models to traditional hospital aftercare require consideration in terms of clinical effectiveness and cost-effectiveness.

Methods

‘Evidence to Inform the Cancer Reform Strategy: The Clinical Effectiveness of Follow-Up Services after Treatment for Cancer’ (Centre for Reviews and Dissemination 2007) has been updated using a number of quality-controlled databases. Correspondence with experts was also sought to identify current initiatives.

Result

The review highlights a shift towards patient empowerment via individualised and group education programmes aimed at increasing survivor’s ability to better manage their condition and the effects of treatment, allowing for self-referral or rapid access to health services when needed. The role of specialist nurses as key facilitators of supportive aftercare is emphasised, as is a move towards technology-based aftercare in the form of telephone or web-based services.

Conclusions

The challenge will be replacing traditional clinic follow-up with alternative methods in a cost-effective way that is either as equally effective, or more so. To establish this, more rigorous trials are needed, with larger sample sizes and longer follow-up assessments.

Implications for cancer survivors

Increasing patient confidence to initiate follow-up specific to their needs is likely to increase the workload of primary care providers, who will need training for this.
Literatur
1.
Zurück zum Zitat Cardy P. Worried Sick: the emotional impact of cancer. 2006, Macmillan Cancer Support. Cardy P. Worried Sick: the emotional impact of cancer. 2006, Macmillan Cancer Support.
2.
Zurück zum Zitat Macmillian Cancer Support. Two Million Reasons: The Cancer Survivorship Agenda. 2008. Macmillian Cancer Support. Two Million Reasons: The Cancer Survivorship Agenda. 2008.
3.
Zurück zum Zitat Allberry J. Cancer Reform Strategy: Maintaining Momentum, Building for the Future – First Annual Report. Department of Health, December 2008. Allberry J. Cancer Reform Strategy: Maintaining Momentum, Building for the Future – First Annual Report. Department of Health, December 2008.
4.
Zurück zum Zitat Lorig K, Sobel DS, Stewart AL, Brown BW, Bandura A, Ritter P, et al. (1999) Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999;37(1):5–14.PubMedCrossRef Lorig K, Sobel DS, Stewart AL, Brown BW, Bandura A, Ritter P, et al. (1999) Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999;37(1):5–14.PubMedCrossRef
5.
Zurück zum Zitat Centre for Reviews and Dissemination (CRD) Evidence to inform the Cancer Reform Strategy: The clinical effectiveness and cost-effectiveness of follow-up services after treatment for cancer. 2007, Centre for Reviews and Dissemination. Centre for Reviews and Dissemination (CRD) Evidence to inform the Cancer Reform Strategy: The clinical effectiveness and cost-effectiveness of follow-up services after treatment for cancer. 2007, Centre for Reviews and Dissemination.
6.
Zurück zum Zitat Collins RF, Bekker H, Dodwell DJ. Follow-up care of patients treated for breast cancer: a structured review. Cancer Treat Rev. 2004;30:19–35.PubMedCrossRef Collins RF, Bekker H, Dodwell DJ. Follow-up care of patients treated for breast cancer: a structured review. Cancer Treat Rev. 2004;30:19–35.PubMedCrossRef
7.
Zurück zum Zitat National Institute of Clinical Excellence (NICE) Guidance on cancer services – improving outcomes in breast cancer. 2002, NICE. National Institute of Clinical Excellence (NICE) Guidance on cancer services – improving outcomes in breast cancer. 2002, NICE.
8.
Zurück zum Zitat Grogan M, Rangan A, Gebski V, et al. The value of follow-up of patients with early breast cancer treated with conservative surgery and radiation therapy. Breast. 2002;11:163–69.PubMedCrossRef Grogan M, Rangan A, Gebski V, et al. The value of follow-up of patients with early breast cancer treated with conservative surgery and radiation therapy. Breast. 2002;11:163–69.PubMedCrossRef
9.
Zurück zum Zitat Richard CS, McLeod R. Follow-up of patients after resection for colorectal cancer: a position paper of the Canadian Society of Surgical Oncology and the Canadian Society of Colon and Rectal Surgeons. Can J Surg. 1997;40:90–100.PubMed Richard CS, McLeod R. Follow-up of patients after resection for colorectal cancer: a position paper of the Canadian Society of Surgical Oncology and the Canadian Society of Colon and Rectal Surgeons. Can J Surg. 1997;40:90–100.PubMed
10.
Zurück zum Zitat Jeffery M, Hickey B, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. . Cochrane Database of Systematic Reviews. 2007(1). Jeffery M, Hickey B, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. . Cochrane Database of Systematic Reviews. 2007(1).
11.
Zurück zum Zitat Renehan AG, Egger M, Saunders MP, et al. Mechanisms of improved survival from intensive follow up in colorectal cancer: a hypothesis. Br J Cancer. 2005;92:430–33.PubMed Renehan AG, Egger M, Saunders MP, et al. Mechanisms of improved survival from intensive follow up in colorectal cancer: a hypothesis. Br J Cancer. 2005;92:430–33.PubMed
12.
Zurück zum Zitat Rosen M, Chan L, Beart RW, et al. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 1998;41:1116–26.PubMedCrossRef Rosen M, Chan L, Beart RW, et al. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 1998;41:1116–26.PubMedCrossRef
13.
Zurück zum Zitat Younes RN, Gross J, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest. 1999;115:1494–99.PubMedCrossRef Younes RN, Gross J, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest. 1999;115:1494–99.PubMedCrossRef
15.
Zurück zum Zitat Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–54.PubMedCrossRef Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–54.PubMedCrossRef
16.
Zurück zum Zitat Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ. 1996;313:665–9.PubMed Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ. 1996;313:665–9.PubMed
17.
Zurück zum Zitat Brown L, Payne S, Royle G. Patient initiated follow up of breast cancer. Psychooncology. 2002;11:346–55.PubMedCrossRef Brown L, Payne S, Royle G. Patient initiated follow up of breast cancer. Psychooncology. 2002;11:346–55.PubMedCrossRef
18.
Zurück zum Zitat Koinberg IL, Fridlund B, Engholm GB, Holmberg L. Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. Eur J Oncol Nurs. 2004;8:109–17.PubMedCrossRef Koinberg IL, Fridlund B, Engholm GB, Holmberg L. Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. Eur J Oncol Nurs. 2004;8:109–17.PubMedCrossRef
19.
Zurück zum Zitat Baildam AD, Keeling F, Thompson L, Bundred N, Hopwood P. Nurse-led surgical follow up clinics for women treated for breast cancer – a randomised controlled trial. Breast Cancer Res Treat. 2004;88:S136–7. Baildam AD, Keeling F, Thompson L, Bundred N, Hopwood P. Nurse-led surgical follow up clinics for women treated for breast cancer – a randomised controlled trial. Breast Cancer Res Treat. 2004;88:S136–7.
20.
Zurück zum Zitat Gulliford T, Opomu M, Wilson E, Hanham I, Epstein R. Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study. BMJ. 1997;314:174–7.PubMed Gulliford T, Opomu M, Wilson E, Hanham I, Epstein R. Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study. BMJ. 1997;314:174–7.PubMed
21.
Zurück zum Zitat Kokko R, Hakama M, Holli K. Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomised trial. Breast Cancer Res Treat. 2005;93:255–60.PubMedCrossRef Kokko R, Hakama M, Holli K. Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomised trial. Breast Cancer Res Treat. 2005;93:255–60.PubMedCrossRef
22.
Zurück zum Zitat Oltra A, Santaballa A, Munárriz B, Pastor M, Montalar J. Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective study. Breast J. 2007;13(6):571–4.PubMedCrossRef Oltra A, Santaballa A, Munárriz B, Pastor M, Montalar J. Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective study. Breast J. 2007;13(6):571–4.PubMedCrossRef
23.
Zurück zum Zitat Macafee DA, Whynes D, Scholefield JH. Risk-stratified intensive follow up for treated colorectal cancer - realistic and cost saving? Colorectal Dis. 2008;10(3):222–30.PubMedCrossRef Macafee DA, Whynes D, Scholefield JH. Risk-stratified intensive follow up for treated colorectal cancer - realistic and cost saving? Colorectal Dis. 2008;10(3):222–30.PubMedCrossRef
24.
Zurück zum Zitat Snyder CF, Earle C, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23(3):254–9.PubMedCrossRef Snyder CF, Earle C, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23(3):254–9.PubMedCrossRef
25.
Zurück zum Zitat Melloni B. Follow-up of patients with curative-intent surgical resection. in press., NSCLC. Melloni B. Follow-up of patients with curative-intent surgical resection. in press., NSCLC.
26.
Zurück zum Zitat Montgomery DA, Krupa K, Wilson C, Cooke TG. Automated telephone follow-up after breast cancer: an acceptability and feasibility pilot study. Br J Cancer. 2008;99(5):704–10.PubMedCrossRef Montgomery DA, Krupa K, Wilson C, Cooke TG. Automated telephone follow-up after breast cancer: an acceptability and feasibility pilot study. Br J Cancer. 2008;99(5):704–10.PubMedCrossRef
27.
Zurück zum Zitat Moore S, Corner J, Haviland J, et al. Nurse-led follow-up and conventional medical follow-up in management of patients with lung cancer: randomised trial. BMJ. 2002;325:1145–47.PubMedCrossRef Moore S, Corner J, Haviland J, et al. Nurse-led follow-up and conventional medical follow-up in management of patients with lung cancer: randomised trial. BMJ. 2002;325:1145–47.PubMedCrossRef
28.
Zurück zum Zitat Beaver K. Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ. 2009;338(7690):337–40. Beaver K. Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ. 2009;338(7690):337–40.
29.
Zurück zum Zitat Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S. Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009;13(1):2–8. Epub 2008 Dec 31.PubMedCrossRef Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S. Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009;13(1):2–8. Epub 2008 Dec 31.PubMedCrossRef
30.
Zurück zum Zitat Koinberg I, Engholm G-B, et al. A health economic evaluation of follow-up after breast cancer surgery: results of an rct study. Acta Oncol. 2009;48(1):99–104.PubMedCrossRef Koinberg I, Engholm G-B, et al. A health economic evaluation of follow-up after breast cancer surgery: results of an rct study. Acta Oncol. 2009;48(1):99–104.PubMedCrossRef
31.
Zurück zum Zitat Mandelblatt JS, Cullen J, Lawrence WF, Stanton AL, Yi B, Kwan L, et al. Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer. J Clin Oncol. 2008;1;26(10):1684–90.CrossRef Mandelblatt JS, Cullen J, Lawrence WF, Stanton AL, Yi B, Kwan L, et al. Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer. J Clin Oncol. 2008;1;26(10):1684–90.CrossRef
32.
Zurück zum Zitat Pinto B. (unpublished) Physical activity promotion in cancer follow-up care. Pinto B. (unpublished) Physical activity promotion in cancer follow-up care.
33.
Zurück zum Zitat Fletcher SG, Clark S, Overstreet DL, Steers WD. An improved approach to follow-up care for the urological patient: drop-in group medical appointments. J Urol. 2006;176(3):1122–6.PubMedCrossRef Fletcher SG, Clark S, Overstreet DL, Steers WD. An improved approach to follow-up care for the urological patient: drop-in group medical appointments. J Urol. 2006;176(3):1122–6.PubMedCrossRef
34.
Zurück zum Zitat Maher J, Jackson L. Patient-triggered follow-up for breast cancer survivors. Ongoing study., Hillingdon Breast Unit Mount Vernon Cancer Centre. Maher J, Jackson L. Patient-triggered follow-up for breast cancer survivors. Ongoing study., Hillingdon Breast Unit Mount Vernon Cancer Centre.
35.
Zurück zum Zitat Chapman D, Cox E, Britton PD, Wishart GC. Patient-led breast cancer follow up. Breast. 2009;18:100–2.PubMedCrossRef Chapman D, Cox E, Britton PD, Wishart GC. Patient-led breast cancer follow up. Breast. 2009;18:100–2.PubMedCrossRef
37.
38.
Zurück zum Zitat Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol. 2005;23(15):3552–61.PubMedCrossRef Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol. 2005;23(15):3552–61.PubMedCrossRef
39.
Zurück zum Zitat Wright P. A web-based two-way information platform for use in low risk cancer survivors post-treatment. ongoing study.: Psychosocial Oncology and Clinical Practice Research Group, St James’s Institute of Oncology, ongoing study. Wright P. A web-based two-way information platform for use in low risk cancer survivors post-treatment. ongoing study.: Psychosocial Oncology and Clinical Practice Research Group, St James’s Institute of Oncology, ongoing study.
40.
Zurück zum Zitat Richardson A, John J, Kelly J, Armes J, Ream E (2009). Surviving Cancer, Living Life” Support Service: An Evaluation. King’s College London. Richardson A, John J, Kelly J, Armes J, Ream E (2009). Surviving Cancer, Living Life” Support Service: An Evaluation. King’s College London.
41.
Zurück zum Zitat Dunn J, WM, Taggert F, Hulme C, Tritter J, Austoker J, et al.. Involving patients in clinical trial design: the experience of the UK iBreast early breast cancer follow-up trial in Poster presentation at the Annual Meeting of the Society for Clinical Trials. 2009. Dunn J, WM, Taggert F, Hulme C, Tritter J, Austoker J, et al.. Involving patients in clinical trial design: the experience of the UK iBreast early breast cancer follow-up trial in Poster presentation at the Annual Meeting of the Society for Clinical Trials. 2009.
42.
Zurück zum Zitat Wille-Jørgensen P, Laurberg S, Påhlman L, Carriquiry L, Lundqvist N, Smedh K, et al. An interim analysis of recruitment to the COLOFOL trial. Colorectal Dis. 2009;11(7):756–8. Wille-Jørgensen P, Laurberg S, Påhlman L, Carriquiry L, Lundqvist N, Smedh K, et al. An interim analysis of recruitment to the COLOFOL trial. Colorectal Dis. 2009;11(7):756–8.
43.
Zurück zum Zitat Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S (2009) Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009; Feb;13(1):2-8. Epub 2008 Dec 31. Chapman D, C.E., Britton PD, Wishart GC, Patient-led breast cancer follow up. The Breast 2009; 18:100–102. Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S (2009) Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009; Feb;13(1):2-8. Epub 2008 Dec 31. Chapman D, C.E., Britton PD, Wishart GC, Patient-led breast cancer follow up. The Breast 2009; 18:100–102.
44.
Zurück zum Zitat Dent J, Allinson A. Self-referral for breast cancer follow-up. ongoing study: Calderdale and Huddersfield NHS Foundation Trust Hospital Trust. Dent J, Allinson A. Self-referral for breast cancer follow-up. ongoing study: Calderdale and Huddersfield NHS Foundation Trust Hospital Trust.
45.
Zurück zum Zitat Dunn J, WM, Taggert F, Hulme C, Tritter J, Austoker J, Mossman J, et al. Involving patients in clinical trial design: The experience of the UK iBreast early breast cancer follow-up trial in Poster presentation at the Annual Meeting of the Society for Clinical Trials. 2009. Dunn J, WM, Taggert F, Hulme C, Tritter J, Austoker J, Mossman J, et al. Involving patients in clinical trial design: The experience of the UK iBreast early breast cancer follow-up trial in Poster presentation at the Annual Meeting of the Society for Clinical Trials. 2009.
46.
Zurück zum Zitat Basch E, Iasonos A., Barz A, Culkin A, Kris MG, Artz D, et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol. 2007; 25(34):5374–80. Basch E, Iasonos A., Barz A, Culkin A, Kris MG, Artz D, et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol. 2007; 25(34):5374–80.
47.
Zurück zum Zitat Pinto BM, Goldstein MG, Papandonatos GD. Promoting physical activity in follow-up care for breast cancer patients. Presented at the Society of Behavioral Medicine Annual Meeting. 2009; Apr 2009. Pinto BM, Goldstein MG, Papandonatos GD. Promoting physical activity in follow-up care for breast cancer patients. Presented at the Society of Behavioral Medicine Annual Meeting. 2009; Apr 2009.
Metadaten
Titel
Towards a personalised approach to aftercare: a review of cancer follow-up in the UK
verfasst von
Nicola J. Davies
Lynn Batehup
Publikationsdatum
01.06.2011
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2011
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0165-3

Weitere Artikel der Ausgabe 2/2011

Journal of Cancer Survivorship 2/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.